REVELATION BIOSCIENCES INC
REVB · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.77
- Today’s Low
- $0.73
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.79
- Previous Close
- $0.77
- Volume
- 12.57K
- Market Cap
- $3.08M
- P/E Ratio
- --
- EPS
- $-6.32
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 4660 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, UNITED STATES, 92122
- Country
- US
- Listing Date
- 2020-10-08
- Fiscal Year End
- December
- Shares Outstanding
- 3.91M
- CIK
- 0001810560
- Website
- www.revbiosciences.com
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.66M
2026-03-31
$3.08M
2025-12-31
$2.57M
2025-09-30
$1.94M
Net Income
2026-06-30
-$3.32M
2026-03-31
-$3M
2025-12-31
-$2.51M
2025-09-30
-$1.9M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.87
2026-03-31
$-2.71
2025-12-31
$-1.65
2025-09-30
$-7.08
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.31M
2026-03-31
-$3.08M
2025-12-31
-$2.56M
2025-09-30
-$1.93M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.66M | $3.08M | $2.57M | $1.94M |
| Net Income | -$3.32M | -$3M | -$2.51M | -$1.9M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.87 | $-2.71 | $-1.65 | $-7.08 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.31M | -$3.08M | -$2.56M | -$1.93M |
| Effective Tax Rate | -- | -- | 0% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.